Home > CDMO Services
CDMO Services
Accelerating Your Molecule from Concept to Commercialization
At Abiozen, we deliver comprehensive Contract Development and Manufacturing (CDMO) services tailored to the evolving needs of pharmaceutical innovators. From early-stage formulation to commercial-scale production, our integrated approach ensures seamless transitions, regulatory excellence, and accelerated time-to-market. Backed by GMP-certified facilities and a commitment to quality, we empower pharmaceutical companies worldwide to bring small molecules, biologics, and sterile injectables to market with confidence and speed.

Integrated Capabilities
From Molecule to Market, Seamlessly Delivered
Formulation Development
Our formulation development services focus on enhancing solubility, bioavailability, and patient-centric delivery using advanced technologies like nanotechnology, lipid-based systems, and controlled-release platforms. Abiozen’s scientists tailor each formulation based on clinical requirements and scalability, conducting rigorous excipient compatibility and pre-formulation studies. Whether for oral, injectable, or complex molecules, we ensure each drug product is optimized for therapeutic performance, regulatory readiness, and manufacturing feasibility.
Process Optimization
Abiozen applies a data-driven, science-first approach to streamline manufacturing processes, reduce variability, and drive efficiency. Using methodologies like Design of Experiments (DoE) and Statistical Process Control (SPC), we identify optimal parameters that translate into consistent, high-quality outcomes. Our teams focus on scalability, process robustness, and regulatory alignment to help clients reduce development timelines, mitigate risk, and increase operational throughput from lab to commercial production.
Scale-Up Manufacturing
From pilot-scale trials to full commercial output, our manufacturing infrastructure supports seamless scale-up across diverse product categories. We offer high-volume API synthesis using advanced reactors and automated systems to ensure precision and consistency. Our GMP-compliant facilities feature ISO Class 5 cleanrooms and cutting-edge equipment, enabling the reliable production of sterile injectables and complex formulations at global scale, with rigorous in-line quality control for every batch.
Custom Synthesis & Lyophilization
Our custom synthesis capabilities allow for the production of complex, high-potency molecules, including peptides and chiral compounds, using techniques like flow chemistry and microwave-assisted synthesis. Complementing this, our advanced lyophilization systems enhance product stability and shelf life through precise freeze-drying under aseptic conditions. These specialized services ensure molecular integrity, sterility, and long-term storage feasibility, meeting the most demanding clinical and commercial requirements.
Analytical Testing & Stability Studies
Our analytical labs deliver robust, ICH-compliant testing services that support drug development from R&D through post-market surveillance. We develop and validate methods using HPLC, GC, and spectroscopy while conducting rigorous batch release testing and contamination control. Stability studies under various conditions generate critical shelf-life data for global regulatory submissions, giving our clients full confidence in product quality, safety, and performance across the product lifecycle.
Expertise across the entire drug development lifecycle
IND Enabling Services
Accelerate regulatory filings with expert IND strategies that ensure speed without compromising quality.
Analytical Testing
Comprehensive analytical support delivering purity, potency, and regulatory-ready data.
Process Development
Resolve early-stage challenges with scalable, validation-ready process design.
Clinical Trial Material Production
GMP-compliant CTM manufacturing with full aseptic processing and flexible batch sizes.
Clinical Supply & Logistics
Global distribution with real-time tracking and packaging tailored to trial protocols.
Trial Management & Biostatistics
Adaptive trial execution with real-time data and regulatory-grade statistical insights.
Commercial Scale Manufacturing
Seamless scale-up to high-volume production with automated sterile filling lines.
Technology Transfer
Validated, risk-mitigated process transfer ensuring global compliance and consistency.
Packaging & Serialization
End-to-end packaging with global serialization and multilingual compliance solutions.
Generic API Manufacturing
High-quality, scalable API production with regulatory-aligned synthesis protocols.
Intermediates and RSMs
Reliable supply of key intermediates and starting materials with global reach and control.
Related Resources

Accelerated Market Access with CRDMO-Style Development & Manufacturing
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Integrated API to Commercial Manufacturing: The Patheon Parallel
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Curia-Level Excellence in End-to-End Drug Development Solutions
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Accelerated Market Access with CRDMO-Style Development & Manufacturing
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Integrated API to Commercial Manufacturing: The Patheon Parallel
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Accelerated Market Access with CRDMO-Style Development & Manufacturing
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste